Abstract
Hyperglycemia is associated with increased morbidity and mortality in critically ill patients. Clinical trial data has demonstrated that controlling hyperglycemia with insulin infusions guided by frequent blood glucose monitoring can reduce this morbidity and mortality. Pharmacoeconomic analyses of these studies have found that tight glycemic control in the critically ill patient is highly cost-effective. Given the relatively small cost of achieving tight glycemic control (about $200 per patient), most economic analyses have demonstrated that tight glycemic control protocols are actually cost saving. Based on the outcomes of cardiac surgery and intensive care unit studies, the cost per life year gained resulting from the implementation of tight glycemic control protocols is less than $6000 (highly cost-effective). Benefits of implementing tight glycemic control protocols in critical or intensive care units includes not only reductions in morbidity and mortality, but reductions in hospital costs.
| Original language | English |
|---|---|
| Pages (from-to) | 359-365 |
| Number of pages | 7 |
| Journal | Seminars in Thoracic and Cardiovascular Surgery |
| Volume | 18 |
| Issue number | 4 |
| DOIs | |
| State | Published - 2006 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Cardiology and Cardiovascular Medicine
Cite this
Cost Considerations with Tight Glycemic Control in the Acute Care Setting. / Hilleman, Daniel E.
In: Seminars in Thoracic and Cardiovascular Surgery, Vol. 18, No. 4, 2006, p. 359-365.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Cost Considerations with Tight Glycemic Control in the Acute Care Setting
AU - Hilleman, Daniel E.
PY - 2006
Y1 - 2006
N2 - Hyperglycemia is associated with increased morbidity and mortality in critically ill patients. Clinical trial data has demonstrated that controlling hyperglycemia with insulin infusions guided by frequent blood glucose monitoring can reduce this morbidity and mortality. Pharmacoeconomic analyses of these studies have found that tight glycemic control in the critically ill patient is highly cost-effective. Given the relatively small cost of achieving tight glycemic control (about $200 per patient), most economic analyses have demonstrated that tight glycemic control protocols are actually cost saving. Based on the outcomes of cardiac surgery and intensive care unit studies, the cost per life year gained resulting from the implementation of tight glycemic control protocols is less than $6000 (highly cost-effective). Benefits of implementing tight glycemic control protocols in critical or intensive care units includes not only reductions in morbidity and mortality, but reductions in hospital costs.
AB - Hyperglycemia is associated with increased morbidity and mortality in critically ill patients. Clinical trial data has demonstrated that controlling hyperglycemia with insulin infusions guided by frequent blood glucose monitoring can reduce this morbidity and mortality. Pharmacoeconomic analyses of these studies have found that tight glycemic control in the critically ill patient is highly cost-effective. Given the relatively small cost of achieving tight glycemic control (about $200 per patient), most economic analyses have demonstrated that tight glycemic control protocols are actually cost saving. Based on the outcomes of cardiac surgery and intensive care unit studies, the cost per life year gained resulting from the implementation of tight glycemic control protocols is less than $6000 (highly cost-effective). Benefits of implementing tight glycemic control protocols in critical or intensive care units includes not only reductions in morbidity and mortality, but reductions in hospital costs.
UR - http://www.scopus.com/inward/record.url?scp=33947528255&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33947528255&partnerID=8YFLogxK
U2 - 10.1053/j.semtcvs.2006.12.004
DO - 10.1053/j.semtcvs.2006.12.004
M3 - Article
C2 - 17395033
AN - SCOPUS:33947528255
VL - 18
SP - 359
EP - 365
JO - Seminars in Thoracic and Cardiovascular Surgery
JF - Seminars in Thoracic and Cardiovascular Surgery
SN - 1043-0679
IS - 4
ER -